Expiration date: 06/2026
Composition:
levetiracetam 250, 500 or 1000 mg
Excipients: crospovidone, povidone, colloidal silicon dioxide, magnesium stearate
Indications:
As monotherapy: partial seizures with secondary generalization or without patients 16 years of age with newly diagnosed epilepsy. As an adjuvant therapy for the treatment of the following conditions: partial seizures with secondary generalization in patients without epilepsy 6 years
myoclonic seizures in patients with juvenile myoclonic epilepsy 12 years
primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy with 12 years.